Abstract:This article presented the metabolic reprogramming of tumor cells to adapt to their microenvironment distinct from normal cells. And this study reviewed the driving factors of metabolic reprogramming, the specific metabolic pathway changes affected, and the related treatment options, in order to provide some suggestions for future tumor treatment. Cancer cells characterized by uncontrolled growth and proliferation require altered metabolic processes to maintain this characteristic. Metabolic reprogramming is a process mediated by various factors, including oncogenes, tumor suppressor genes, changes in growth factors, and tumor–host cell interactions, which help to meet the needs of cancer cell anabolism and promote tumor development. Metabolic reprogramming in tumor cells is dynamically variable, depending on the tumor type and microenvironment, and reprogramming involves multiple metabolic pathways. These metabolic pathways have complex mechanisms and involve the coordination of various signaling molecules, proteins, and enzymes, which increases the resistance of tumor cells to traditional antitumor therapies. With the development of cancer therapies, metabolic reprogramming has been recognized as a new therapeutic target for metabolic changes in tumor cells. Therefore, understanding how multiple metabolic pathways in cancer cells change can provide a reference for the development of new therapies for tumor treatment. Here, we systemically reviewed the metabolic changes and their alteration factors, together with the current tumor regulation treatments and other possible treatments that are still under investigation. Continuous efforts are needed to further explore the mechanism of cancer metabolism reprogramming and corresponding metabolic treatments.

Therapeutic strategies targeting metabolic characteristics of cancer cells

Metabolic reprogramming in cancer: Mechanisms and therapeutics

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Metabolic Targeting of Cancers: from Molecular Mechanisms to Therapeutic Strategies

Targeting cellular metabolism to improve cancer therapeutics

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

Metabolic interventions: A new insight into the cancer immunotherapy

Targeting Mitochondrial Metabolic Reprogramming As a Potential Approach for Cancer Therapy

Cancer metabolism and carcinogenesis

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics

Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy

Targeting T Cell Metabolism in the Tumor Microenvironment: an Anti-Cancer Therapeutic Strategy

Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect

[Metabolic reprogramming in cancer: the art of balance].

Therapeutic Targets of Tumor Metabolism

Cancer Metabolism and Intervention Therapy

Metabolism in Cancer Stem Cells: Targets for Clinical Treatment